OCOEE, FL - iCoreConnect Inc. (NASDAQ: ICCT), a cloud-based software and technology company, has announced a significant original equipment manufacturer (OEM) partnership with Carestream Dental. The collaboration involves the integration of iCoreConnect's Rx Manager with Carestream Dental's Sensei practice and patient management brand.
This partnership aims to enhance the workflow productivity and customer profitability for users of Sensei offerings, which include Sensei Cloud, OrthoTrac, PracticeWorks, SoftDent, and WinOMS. Through the integration, these platforms will gain access to comprehensive features such as cloud access, medication history, drug interactions, and ePrescribing capabilities.
Key highlights of the integration underscore the streamlined workflow processes, an improved user experience with intuitive interfaces, and enterprise scalability and flexibility to meet the evolving needs of businesses. The partnership is expected to provide long-term value and return on investment for users.
Monica Minore, chief revenue officer at Sensei, expressed enthusiasm about the partnership, stating, "This collaboration exemplifies our commitment to providing best-in-class solutions that empower businesses to thrive in today's dynamic marketplace."
The information in this article is based on a press release statement.
InvestingPro Insights
As iCoreConnect Inc. (NASDAQ: ICCT) forges ahead with its strategic partnership with Carestream Dental, the company's financial health and stock performance are key factors for investors to consider. Here's some essential data from InvestingPro to provide a clearer picture:
The company's market capitalization stands at $15.1 million, reflecting its current valuation in the market. While the market cap provides a snapshot of company size, other metrics reveal more about its performance. iCoreConnect has a negative P/E ratio of -21.63, indicating that investors are shouldering losses for now. This is underscored by the company's lack of profitability over the last twelve months, a critical point for potential investors to consider.
Despite recent challenges, iCoreConnect has shown a strong return over the last three months, with a 56.25% price total return, suggesting a possible turnaround or positive market reaction to recent developments. However, this is set against a backdrop of a significant 85.52% drop in the one-year price total return, which may raise concerns about the stock's volatility and longer-term performance.
For those considering an investment in iCoreConnect, it's important to note that the company does not pay a dividend to shareholders, which could be a factor for those seeking income-generating investments. Moreover, with short-term obligations exceeding liquid assets, the company's short-term financial health might be under scrutiny.
Investors looking to delve deeper into iCoreConnect's financials and stock performance can find additional InvestingPro Tips on the platform. As of now, there are 5 more tips available that can provide further insights into the company's prospects. To access these tips and more detailed analytics, visit https://www.investing.com/pro/ICCT. Don't forget to use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.